Concepedia
Statistics
Publications
6
Citations
356
H-Index
Active since
1995
Affiliations
University of Freiburg(Current)
Boehringer Ingelheim (Germany)
Bayer (Germany)
Daniela Gmehling is an author at University of Freiburg specializing in medicine, pharmacology, and cancer pharmacology.
Publications per year
1995–2009
Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
K. Mross, Martin Štefanič, Daniela Gmehling et al. · Clinical Cancer Research · 2009 · 169 citations
Medicine, Oncology, Pharmacology +16
Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib
K. Mross, Simone Steinbild, F. Baas et al. · European Journal of Cancer · 2006 · 101 citations
Medicine, Pharmacokinetics, Pharmacology +8
A clinical phase I, pharmacokinetic (PK), and pharmacodynamic study of twice daily BIBF 1120 in advanced cancer patients
K. Mross, Daniela Gmehling, Annette Frost et al. · Journal of Clinical Oncology · 2005 · 26 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacology +17
Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and <i>Leishmania major</i>‐infected mice
H Thüring, Steffen Stenger, Daniela Gmehling et al. · European Journal of Immunology · 1995 · 24 citations
Life Sciences, Immunology, Pathobiology +15
Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical Experience
Annette Frost, Daniela Gmehling, Marc Azémar et al. · Oncology Research and Treatment · 2006 · 21 citations
Medicine, Oncology, Pharmacotherapy +14
1–5 of 6